As of 2025-04-18, the Relative Valuation of Biodesix, Inc. (BDSX) is (4.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Biodesix, Inc. based on Relative Valuation is -841.9%.
The range of the Relative Valuation is (3.52) - (4.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 15.3x | 13.0x |
| Forward P/E multiples | 10.9x - 18.5x | 14.8x |
| Fair Price | (3.52) - (4.51) | (4.07) |
| Upside | -740.7% - -921.7% | -841.9% |
| Date | P/E |
| 2025-04-03 | -2.02 |
| 2025-04-02 | -2.13 |
| 2025-04-01 | -2.06 |
| 2025-03-31 | -2.13 |
| 2025-03-28 | -2.28 |
| 2025-03-27 | -2.42 |
| 2025-03-26 | -2.56 |
| 2025-03-25 | -2.74 |
| 2025-03-24 | -2.82 |
| 2025-03-21 | -2.88 |
| 2025-03-20 | -2.77 |
| 2025-03-19 | -2.78 |
| 2025-03-18 | -2.60 |
| 2025-03-17 | -2.55 |
| 2025-03-14 | -2.46 |
| 2025-03-13 | -2.53 |
| 2025-03-12 | -2.66 |
| 2025-03-11 | -2.78 |
| 2025-03-10 | -2.74 |
| 2025-03-07 | -2.93 |
| 2025-03-06 | -2.89 |
| 2025-03-05 | -2.96 |
| 2025-03-04 | -2.45 |
| 2025-03-03 | -2.42 |
| 2025-02-28 | -2.70 |
| 2025-02-27 | -2.76 |
| 2025-02-26 | -2.83 |
| 2025-02-25 | -2.72 |
| 2025-02-24 | -2.85 |
| 2025-02-21 | -3.00 |
| 2025-02-20 | -3.13 |
| 2025-02-19 | -3.21 |
| 2025-02-18 | -3.30 |
| 2025-02-14 | -3.35 |
| 2025-02-13 | -3.27 |
| 2025-02-12 | -3.20 |
| 2025-02-11 | -3.23 |
| 2025-02-10 | -3.23 |
| 2025-02-07 | -3.40 |
| 2025-02-06 | -3.54 |
| 2025-02-05 | -3.57 |
| 2025-02-04 | -3.40 |
| 2025-02-03 | -3.43 |
| 2025-01-31 | -3.50 |
| 2025-01-30 | -3.54 |
| 2025-01-29 | -3.54 |
| 2025-01-28 | -3.57 |
| 2025-01-27 | -3.57 |
| 2025-01-24 | -3.50 |
| 2025-01-23 | -3.06 |